ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 378734 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 378734; 2) Community: the network communities that were significantly associated with the response to NSC 378734; 3) Molecule: the relationships between components within communities and NSC 378734; 4) MDR: the compounds that were significantly associated with the NSC 378734.

NSC Compound Enrichment Correlation
NSC 698960 Null 0.0181211508101519 0.051341387
NSC 702348 Null 0.0181211508101519 -0.042013349
NSC 649082 Null 0.0199123109106645 0.32263144
NSC 729797 5-({[4-(1,3-benzoxazol-2-yl)phenyl]amino}methylene)pyrimidin e-2,4,6(1H,3H,5H)-trione 0.0199123109106645 -0.2071216
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0209467683758282 0.10328916
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0209467683758282 0.00080104455
NSC 126728 WLN: T B-18-56 C6 A 2BC D& AX CX EOV KOV QVO VO MU OU A&UTJ B1 GQH1 B&1 A-& BT3OX CHJ 0.0209467683758283 0.23864971
NSC 129790 Null 0.0209467683758286 0.2746137
NSC 144126 Null 0.0209467683758286 0.32490012
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0209467683758286 0.34433651
Total:52  Current:20    [First] [Prev] [Next] [Last]